The oriented development of antituberculotics: salicylanilides.
Waisser K, Matyk J, Divisová H, Husáková P, Kunes J, Klimesová V, Kaustová J, Möllmann U, Dahse HM, Miko M.
Waisser K, et al. Among authors: kaustova j.
Arch Pharm (Weinheim). 2006 Nov;339(11):616-20. doi: 10.1002/ardp.200600093.
Arch Pharm (Weinheim). 2006.
PMID: 17048291